Metis Global Partners LLC Purchases 84 Shares of STERIS plc (NYSE:STE)

Metis Global Partners LLC grew its position in STERIS plc (NYSE:STE) by 1.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,450 shares of the medical equipment provider’s stock after acquiring an additional 84 shares during the period. Metis Global Partners LLC’s holdings in STERIS were worth $1,322,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. West Coast Financial LLC lifted its stake in STERIS by 2.8% in the 3rd quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider’s stock valued at $398,000 after purchasing an additional 45 shares during the last quarter. Taylor Frigon Capital Management LLC boosted its stake in shares of STERIS by 0.8% during the 2nd quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider’s stock worth $1,356,000 after acquiring an additional 46 shares during the period. Mather Group LLC. increased its holdings in shares of STERIS by 7.6% during the 2nd quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock worth $172,000 after acquiring an additional 54 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in STERIS by 16.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider’s stock valued at $82,000 after acquiring an additional 57 shares during the period. Finally, Waterloo Capital L.P. lifted its holdings in STERIS by 3.2% during the 2nd quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider’s stock valued at $421,000 after purchasing an additional 59 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have commented on STE shares. KeyCorp upped their price objective on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a report on Tuesday, September 3rd. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Wednesday, August 7th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, November 8th. Stephens reiterated an “overweight” rating and set a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. Finally, StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, STERIS presently has an average rating of “Moderate Buy” and a consensus price target of $253.00.

STERIS Stock Down 0.5 %

Shares of STE opened at $220.12 on Friday. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. STERIS plc has a 12 month low of $195.47 and a 12 month high of $248.24. The firm’s 50 day moving average is $230.37 and its 200-day moving average is $228.26. The stock has a market capitalization of $21.73 billion, a PE ratio of 50.26 and a beta of 0.85.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.03 earnings per share. Equities research analysts forecast that STERIS plc will post 9.15 EPS for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Tuesday, November 19th. STERIS’s dividend payout ratio (DPR) is presently 52.05%.

Insider Buying and Selling

In other news, CFO Michael J. Tokich sold 23,332 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the completion of the transaction, the chief financial officer now directly owns 42,930 shares in the company, valued at approximately $10,603,710. The trade was a 35.21 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by company insiders.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.